Levicatus Mugenyi
Overview
Explore the profile of Levicatus Mugenyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mugenyi L, Nanfuka M, Byawaka J, Agaba C, Mijumbi A, Kagimu D, et al.
PLoS One
. 2022 May;
17(5):e0268226.
PMID: 35580126
Background: Few studies have analysed the effect of HIV universal test and treat (UTT) on retention and mortality among people living with HIV (PLHIV) in routine care. We examined six-month...
12.
Kazibwe A, Oryokot B, Mugenyi L, Kagimu D, Oluka A, Kato D, et al.
PLoS One
. 2022 May;
17(5):e0266285.
PMID: 35576223
Introduction: Isoniazid preventive therapy (IPT) is effective in treating tuberculosis (TB) infection and hence limiting progression to active disease. However, the durability of protection, associated factors and cost-effectiveness of IPT...
13.
Mugenyi L, Mijumbi A, Nanfuka M, Agaba C, Kaliba F, Semakula I, et al.
BMC Med Ethics
. 2021 Dec;
22(1):165.
PMID: 34911524
Background: Community engagement is a key component in health research. One of the ways health researchers ensure community engagement is through Community Advisory Boards (CABs). The capacity of CABs to...
14.
Nidoi J, Muttamba W, Walusimbi S, Imoko J, Lochoro P, Ictho J, et al.
BMC Public Health
. 2021 Nov;
21(1):2167.
PMID: 34836521
Background: Tuberculosis (TB) is a major public health problem and at 48%, Karamoja in North-Eastern Uganda has the lowest treatment success rate nationally. Addressing the social determinants of TB is...
15.
Mugenyi L, Nsubuga R, Wanyana I, Muttamba W, Tumwesigye N, Nsubuga S
PLoS One
. 2021 Nov;
16(11):e0260269.
PMID: 34797878
Background: Feasibility of mobile Apps to monitor diseases has not been well documented particularly in developing countries. We developed and studied the feasibility of using a mobile App to collect...
16.
Birungi J, Kivuyo S, Garrib A, Mugenyi L, Mutungi G, Namakoola I, et al.
BMJ Open
. 2021 Nov;
11(11):e053412.
PMID: 34728457
Background: HIV, diabetes and hypertension have a high disease burden in sub-Saharan Africa. Healthcare is organised in separate clinics, which may be inefficient. In a cohort study, we evaluated integrated...
17.
Matovu J, Bukenya J, Kasozi D, Kisaka S, Kisa R, Nyabigambo A, et al.
PLoS One
. 2021 Sep;
16(9):e0257321.
PMID: 34506577
Background: Adolescent girls and young women (AGYW) are at increased risk of sexually transmitted infections (STIs). We assessed sexual-risk behaviours and HIV and syphilis prevalence among AGYW in Uganda to...
18.
Kirenga B, Byakika-Kibwika P, Muttamba W, Kayongo A, Loryndah N, Mugenyi L, et al.
BMJ Open Respir Res
. 2021 Aug;
8(1).
PMID: 34376401
Rationale: Convalescent plasma (CCP) has been studied as a potential therapy for COVID-19, but data on its efficacy in Africa are limited. Objective: In this trial we set out to...
19.
Muttamba W, Lusiba J, Namakula L, Byakika-Kibwika P, Ssali F, Ddungu H, et al.
PLoS One
. 2021 Jun;
16(6):e0252306.
PMID: 34138909
Introduction: Evidence that supports the use of COVID-19 convalescent plasma (CCP) for treatment of COVID-19 is increasingly emerging. However, very few African countries have undertaken the collection and processing of...
20.
Alupo P, Wosu A, Mahofa A, Mugenyi L, Semakula D, Katagira W, et al.
PLoS One
. 2021 Feb;
16(2):e0246850.
PMID: 33571315
Background: Data is lacking on outcomes among COPD patients in sub-Saharan Africa. The objective of the study was to assess the incidence and predictors of mortality among COPD patients enrolled...